ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 33530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 33530; 2) Community: the network communities that were significantly associated with the response to NSC 33530; 3) Molecule: the relationships between components within communities and NSC 33530; 4) MDR: the compounds that were significantly associated with the NSC 33530.

NSC Compound Enrichment Correlation
NSC 53327 Null 0.0244632509325736 0.19615504
NSC 600758 Null 0.0244632509325736 0.39676747
NSC 603831 Acteoside 0.0244632509325736 0.06162371
NSC 610458 Camptothecin Derivative 0.0244632509325736 0.1693154
NSC 612789 Acrovestone 0.0244632509325736 0.27984536
NSC 631391 7H-Pyrido[4,3-c]carbazole-6-methanol,methylcarbamate (ester) (9CI) 0.0244632509325736 0.35579776
NSC 639174 Camptothecin Derivative 0.0244632509325736 0.24507812
NSC 639186 Raltitrexed 0.0244632509325736 0.24663848
NSC 679716 1H-Pyrazole-3-carboxylic acid, 5-benzoyl-4,5-dihydro- 4-phenyl-, ethyl ester 0.0244632509325736 0.36811246
NSC 682835 Propanimidoyl chloride, N-[[[(5-fluoro-2-methylphenyl) amino]carbonyl]oxy]- 0.0244632509325736 0.4161523
Total:99  Current:57    [First] [Prev] [Next] [Last]